| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 0.8 | 0.0 | 0.0 |
| Total income | 0.9 | 0.0 | 0.0 |
| Profit before exceptional items & tax | 0.3 | -0.1 | -0.1 |
| Profit before tax | 0.3 | -0.1 | -0.1 |
| Net profit | 0.3 | -0.1 | -0.1 |
| Operating margin | 33.3% | 0.0% | 0.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
BSE results filing, NSE: HINDBIO. Figures extracted from the filing.
Hindustan Bio Sciences Ltd: key numbers
- Share price
- ₹6.68
- Market cap
- ₹6.85 Cr
- Revenue (annual)
- ₹0.74 Cr
- Net profit (annual)
- ₹-0.08 Cr
- P/E (TTM)
- -33.2×Sector 45.9×
- Promoter holding
- 12.19%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hindustan Bio Sciences Ltd
All →Hindustan Bio Sciences Management Change
Hindustan Bio Sciences' Company Secretary and Compliance Officer Shailendra Vyas resigned, effective October 31, 2026. He cited an alternate career opportunity.
Hindustan Bio Sciences Board Meeting Date
Hindustan Bio Sciences Ltd intimated a board meeting on October 31, 2026 to consider unaudited financial results for the quarter ended September 30, 2026. The agenda items are proposed only; no results are yet approved.
Hindustan Bio Sciences Other Announcement
Hindustan Bio Sciences Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, pursuant to SEBI Regulation 31(1)(b).
Hindustan Bio Sciences Annual General Meeting
Hindustan Bio Sciences Ltd held its 34th Annual General Meeting on September 30, 2026. The meeting transacted business including adoption of financial statements and capital reduction.
Hindustan Bio Sciences Annual General Meeting
Hindustan Bio Sciences Limited has issued a notice for its 34th Annual General Meeting to be held on September 30, 2026, in Hyderabad.
Hindustan Bio Sciences Annual Report
Hindustan Bio Sciences Ltd submitted its 34th Annual Report for FY 2025-26, containing the AGM notice proposing a scheme of capital reduction.